Clinical Trial Update: Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the immune response and safety of an investigational Group B Streptococcus vaccine in pregnant women and their offspring.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcal Infection
• Neonatal Meningitis
• Neonatal Sepsis

Drugs mentioned

• Group B streptococcal vaccine (investigational)

Snippet

Sponsor: Novartis | Conditions: Streptococcal Infection, Gram-positive Bacterial Infection | Phase 2 | Status: COMPLETED | Results posted: 2014-09-08